首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1697439

臉部注射劑市場：未來預測（2025-2030）

Facial Injectable Market - Forecasts from 2025 to 2030

出版日期: 2025年02月19日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計 2025 年臉部注射劑市場價值將達到 183.1 億美元，到 2030 年預計將達到 320.8 億美元，複合年成長率為 11.87%。

隨著消費者越來越關注自己的外表，臉部注射劑的需求也不斷增加。在全球範圍內，隨著人口的很大一部分變得更容易受到各種衰老徵兆的影響，臉部注射劑的需求也在上升。與老齡化相關的症狀，如老年斑、皺紋、皮膚鬆弛和臉部彈性喪失，在 25 歲至 30 歲之間開始變得明顯，並在 30 歲至 65 歲之間從中度到重度不等。

此外，不斷成長的需求和新技術的發展正在透過主要企業的各種美容宣傳活動提高人們對微創手術的認知，進一步推動市場擴張。

市場趨勢：

價格實惠的臉部注射劑和對美容的日益重視推動了行業成長：具有成本效益的臉部注射劑的可用性以及對美容和美容程序的日益重視正在擴大該行業。例如，24% 的成年人表示至少接受過一次整容手術。近年來，隨著人們美學訴求的不斷提升以及先進美容護理的便捷獲取，化妝品行業蓬勃發展。技術進步進一步支持了這一趨勢，確保快速恢復、最大限度降低感染風險、無需輸血並降低手術成本。
人們越來越偏好微創治療：臉部注射劑等微創治療越來越受歡迎，因為它們被認為更安全、更容易忍受且幾乎不需要停機時間。注射劑的主要類型包括神經調節劑（如肉毒桿菌）和真皮填充劑（如氫氧化鈣和透明質酸）。
亞太地區市場快速成長：由於中國、日本和印度等國家強勁的成長前景，預計預測期內亞太地區的臉部注射劑市場將大幅成長。這一成長背後的關鍵因素包括都市化加快、患者意識增強以及可支配收入增加。此外，該地區人口老化可能是需求的主要驅動力。

報告中介紹的主要企業包括艾爾建（AbbVie Inc）、博士倫醫療集團（Bausch Health Companies Inc.）、華熙生物科技股份有限公司（Bloomage Biotechnology Corporation Limited）、高德美（Galderma）等。

本報告的主要優點

深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適用範圍廣：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

臉部注射劑市場細分為：

依產品類型

肉毒桿菌毒素
膠原蛋白
玻尿酸
顆粒/聚合物填料（PPF）
羥磷石灰鈣
聚左旋乳酸
聚甲基丙烯酸甲酯
其他

按應用

美麗
治療

按最終用戶

皮膚科和美容診所
醫院
研究所

按地區

北美洲
歐洲
亞太地區
南美洲
中東和非洲

介紹
北美洲
- 依產品類型
- 按應用
- 按最終用戶
- 按國家
南美洲
- 依產品類型
- 按應用
- 按最終用戶
- 按國家
歐洲
- 依產品類型
- 按應用
- 按最終用戶
- 按國家
中東和非洲
- 依產品類型
- 按應用
- 按最終用戶
- 按國家
亞太地區
- 依產品類型
- 按應用
- 按最終用戶
- 按國家

第8章競爭格局及分析

主要企業和策略分析
市場佔有率分析
企業合併、協議、商業合作
競爭儀錶板

第9章公司簡介

Allergan（AbbVie Inc）
Bausch Health Companies Inc.
Bloomage Biotechnology Corporation Limited
Galderma
Ipsen Biopharmaceuticals Inc
Merz Pharma
Prollenium Medical Technologies
Sanofi
Sinclair Pharma
Suneva Medical

第10章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
分析方法
簡稱

簡介目錄

Product Code: KSI061613726

The facial injectable market, valued at US$18.310 billion in 2025, is projected to grow at a CAGR of 11.87%, reaching US$32.083 billion in 2030.

The demand for facial injectables is rising due to consumers' increased emphasis on physical appearance. Globally, the demand for facial injectables has also increased as a large population is susceptible to various signs of aging. The age-related symptoms of dark spots, creases, and saggy skin-that is, low facial elasticity-start to surface from 25 to 30 years and range from moderate to high severity from 30 to 65 years of age.

Moreover, growing demand and new technological developments have increased awareness of minimally invasive procedures due to the various beauty campaigns initiated by leading companies, further driving the market expansion.

Market Trends:

Industry growth driven by affordable facial injectables and rising aesthetic awareness: The industry is expanding due to the availability of cost-effective facial injectables and a growing emphasis on aesthetic consciousness and cosmetic procedures. For example, 24% of adults have reported undergoing at least one cosmetic procedure. The cosmetics sector has flourished in recent years, fueled by heightened aesthetic appeal and the accessibility of advanced cosmetic treatments. This trend is further supported by technological advancements that ensure quick recovery, minimal risk of infection, no blood loss, and reduced procedural costs.
Rising preference for minimally invasive procedures: Minimally invasive treatments, such as facial injectables, are gaining popularity as they are perceived as safer, easier to tolerate, and require little to no downtime. Key types of injectables include neuromodulators, like botulinum toxin, and dermal fillers, such as calcium hydroxylapatite and hyaluronic acid.
Asia-Pacific's rapid market growth: The facial injectable market in the Asia-Pacific region is expected to grow significantly during the forecast period, driven by strong growth prospects in countries like China, Japan, and India. Key factors contributing to this growth include increasing urbanization, rising patient awareness, and higher disposable incomes. Additionally, the region's large aging population is likely to be a major driver of demand.

Some of the major players covered in this report include including Allergan (AbbVie Inc), Bausch Health Companies Inc., Bloomage Biotechnology Corporation Limited, and Galderma, among others:

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Facial Injectable Market is analyzed into the following segments:

By Product Type

Botulinum Toxin
Collagen
Hyaluronic Acid
Particle & Polymer Fillers (PPF)
Calcium Hydroxyapatite
Poly-l-Lactic Acid
Polymethylmethacrylate
Others

By Application

Aesthetics
Therapeutics

By End-Users

Dermatology & Beauty Clinics
Hospitals
Research Institutes

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. FACIAL INJECTABLE MARKET BY PRODUCT TYPE

4.1. Introduction
4.2. Botulinum Toxin
4.3. Collagen
4.4. Hyaluronic Acid
- 4.4.1. Particle & Polymer Fillers (PPF)
- 4.4.2. Calcium Hydroxyapatite
- 4.4.3. Poly-l-Lactic Acid
- 4.4.4. Polymethylmethacrylate
4.5. Others

5. FACIAL INJECTABLE MARKET BY APPLICATION

5.1. Introduction
5.2. Aesthetics
5.3. Therapeutics

6. FACIAL INJECTABLE MARKET BY END-USERS

6.1. Introduction
6.2. Dermatology & Beauty Clinics
6.3. Hospitals
6.4. Research Institutes

7. FACIAL INJECTABLE MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. By Product Type
- 7.2.2. By Application
- 7.2.3. By End-User
- 7.2.4. By Country
  - 7.2.4.1. USA
  - 7.2.4.2. Canada
  - 7.2.4.3. Mexico
7.3. South America
- 7.3.1. By Product Type
- 7.3.2. By Application
- 7.3.3. By End-User
- 7.3.4. By Country
  - 7.3.4.1. Brazil
  - 7.3.4.2. Argentina
  - 7.3.4.3. Others
7.4. Europe
- 7.4.1. By Product Type
- 7.4.2. By Application
- 7.4.3. By End-User
- 7.4.4. By Country
  - 7.4.4.1. Germany
  - 7.4.4.2. France
  - 7.4.4.3. United Kingdom
  - 7.4.4.4. Italy
  - 7.4.4.5. Spain
  - 7.4.4.6. Others
7.5. Middle East and Africa
- 7.5.1. By Product Type
- 7.5.2. By Application
- 7.5.3. By End-User
- 7.5.4. By Country
  - 7.5.4.1. UAE
  - 7.5.4.2. Saudi Arabia
  - 7.5.4.3. Others
7.6. Asia Pacific
- 7.6.1. By Product Type
- 7.6.2. By Application
- 7.6.3. By End-User
- 7.6.4. By Country
  - 7.6.4.1. China
  - 7.6.4.2. Japan
  - 7.6.4.3. South Korea
  - 7.6.4.4. India
  - 7.6.4.5. Thailand
  - 7.6.4.6. Indonesia
  - 7.6.4.7. Others